Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 155.00 | |
5 mg | In stock | $ 397.00 | |
10 mg | In stock | $ 628.00 | |
25 mg | In stock | $ 978.00 | |
50 mg | In stock | $ 1,290.00 | |
100 mg | In stock | $ 1,770.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 512.00 |
Description | Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies. |
Synonyms | MK-1602 |
Molecular Weight | 549.54 |
Formula | C29H26F3N5O3 |
CAS No. | 1374248-77-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (445.83 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ubrogepant 1374248-77-7 GPCR/G Protein Neuroscience CGRP Receptor MK 1602 MK-1602 inhibit Inhibitor Calcitonin gene-related peptide receptor MK1602 inhibitor